Største aksjonær i IDEX i kjempetrøbbel
STORFOND STANSER INNLØSING: Woodford stanser nå innløsninger fra sitt drøye NOK 40 milliarder store aksjefond etter svake resultater og innløsninger over flere år. En frys på innløsning ble innført når en større aktør ba om tilbakebetaling av nærmere NOK 2,7 milliarder. Woodford eier nærmere 25 prosent av Thin Film som er på kapitaljakt og 28 prosent av Idex – tunge posisjoner som det synes svært vanskelig å komme seg ut av med tanke på likviditeten. Idex steg raskt 16 prosent på fredag – siste noteringsdag i mai – på en måte som fikk flere aktører inne på Xtrainvestor til å spekulere i en «pump» for at noen ville vise bedre forvaltningsresultater for måneden. Kursen falt da også kraftig tilbake på mandag. Her finner du vår Idex-kanal https://www.xtrainvestor.com/channel/idex
IDEX vil nok straks reprises mot peers... Da snakker vi et fall på 85% til 43øre
IDEX vil nok straks reprises mot peers... Da snakker vi et fall på 85% til 43øre
Redigert 21.01.2021 kl 09:37
Du må logge inn for å svare
H-Capital
01.10.2019 kl 07:42
4189
Spennende Reserven!
Hva er ditt best guess på når aksjene kommer for salg i markedet?
Hva er ditt best guess på når aksjene kommer for salg i markedet?
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Et utdrag fra:
30.09.2019: https://www.ft.com/content/3e0320ba-e37e-11e9-9743-db5a370481bc
Neil Woodford is now a Patient fund manager in name only
Investment trust is leaving him little to do but sell holdings and repay debt
«Neil Woodford used to be the biggest name in fund management. Now he seems to be a fund manager in name only. On Monday the board of Woodford Patient Capital Trust talked about the “decisive and proactive measures” it had taken with the aim of “protecting shareholders” from Mr Woodford’s investment choices — and said it “remains in dialogue with other potential managers”. It was tantamount to having a security guard stand over him while his successor measured up for new curtains.
Despite that less than ringing endorsement, amid the continuing suspension of the separate Woodford Equity Income Fund following an investor exodus, the manager tried to look on the bright side. “While shareholders can be forgiven for thinking there are no positives,” he said, absolving those who felt a sharp fall in net asset value was a negative, “I continue to believe that the majority of the businesses we have invested in are making good progress.” However, the board doesn’t want him to progress anything further, having taken control of almost all decisions.
Valuation of the unlisted holdings has been completely reassessed “following [a] mandate from the board”, with the results reviewed by accountants Grant Thornton.
Approval of investment decisions now lies with board members who are “more active, hands-on and fully engaged”, in the words of one insider — and, unlike chairman Susan Searle, more obviously independent of the manager, following the hiring of a third non-executive director with no past connection to Mr Woodford. Approval of any new investments has already been given to the trust’s lender, Northern Trust, in return for flexibility over a £150m borrowing facility.
“Liquidity management” also seems to reside with the board, which said it was “working closely with its advisers” to consider raising a limit on unquoted investments beyond 80 per cent — it now stands at 79 per cent as quoted assets have lost value, been sold down, or been delisted in the Channel Islands.
Deleveraging has been forced on the manager by the board, as well, to avoid breaching another limit: borrowing no more than 20 per cent of NAV, which today’s debt of £111m could represent if valuations fall again. Renewing that borrowing facility by January is now the board’s job — and priority.
That leaves Mr Woodford with nothing to do but sell more holdings, repay the bank and clear out his desk for one of those new “potential managers”. It is arguably not the best use of his talents. On the same day that the Patient Capital Trust lost its patience with him, the UK government announced a £200m cash injection alongside £400m of private investment into precisely the type of unquoted science companies that Mr Woodford seeks to back. He may yet continue to do so, but not at WPCT. Judging by the board’s words, and Mr Woodford’s deeds — he sold a £1m stake but didn’t tell directors for three weeks — the curtain is coming down.»
----- ----- ----- ----- ----- -----
Anta, helt hypotetisk, at WPCT styret, enten selv, eller WPCTs nye forvalter, bestemmer seg for å selge WPCTs 50 millioner IDEX aksjer i markedet. Med vanlig IDEX volum, vil et slikt salg ta godt over ett år, og mest sannsynlig senke kursen, med mindre det skjer noe historisk reellt positivt i IDEX som fører til at CBE kan skimtes i det fjerne.
Hvis WPCT bestemmer seg for å selge WPCTs IDEX aksjer, hva gjør da Woodford med WEIFs IDEX aksjer?
Ingen ting, sitter rolig og satser på at IDEX ikke går konk og lykkes med smartkort, slik at kursen går opp - eller tar lærdom av feilene fra THIN, og selger WEIFs IDEX aksjer?
EDIT:
I andre FT artikler står det at WPCT styret i lengre tid har søkt etter en ny forvalter av WPCT. Hvis ingen annen forvalter vil ta over det skakkjørte fondet, hva gjør WPCT styret da? Forvalter det selv, eller avvikler/likviderer fondet?
30.09.2019: https://www.ft.com/content/3e0320ba-e37e-11e9-9743-db5a370481bc
Neil Woodford is now a Patient fund manager in name only
Investment trust is leaving him little to do but sell holdings and repay debt
«Neil Woodford used to be the biggest name in fund management. Now he seems to be a fund manager in name only. On Monday the board of Woodford Patient Capital Trust talked about the “decisive and proactive measures” it had taken with the aim of “protecting shareholders” from Mr Woodford’s investment choices — and said it “remains in dialogue with other potential managers”. It was tantamount to having a security guard stand over him while his successor measured up for new curtains.
Despite that less than ringing endorsement, amid the continuing suspension of the separate Woodford Equity Income Fund following an investor exodus, the manager tried to look on the bright side. “While shareholders can be forgiven for thinking there are no positives,” he said, absolving those who felt a sharp fall in net asset value was a negative, “I continue to believe that the majority of the businesses we have invested in are making good progress.” However, the board doesn’t want him to progress anything further, having taken control of almost all decisions.
Valuation of the unlisted holdings has been completely reassessed “following [a] mandate from the board”, with the results reviewed by accountants Grant Thornton.
Approval of investment decisions now lies with board members who are “more active, hands-on and fully engaged”, in the words of one insider — and, unlike chairman Susan Searle, more obviously independent of the manager, following the hiring of a third non-executive director with no past connection to Mr Woodford. Approval of any new investments has already been given to the trust’s lender, Northern Trust, in return for flexibility over a £150m borrowing facility.
“Liquidity management” also seems to reside with the board, which said it was “working closely with its advisers” to consider raising a limit on unquoted investments beyond 80 per cent — it now stands at 79 per cent as quoted assets have lost value, been sold down, or been delisted in the Channel Islands.
Deleveraging has been forced on the manager by the board, as well, to avoid breaching another limit: borrowing no more than 20 per cent of NAV, which today’s debt of £111m could represent if valuations fall again. Renewing that borrowing facility by January is now the board’s job — and priority.
That leaves Mr Woodford with nothing to do but sell more holdings, repay the bank and clear out his desk for one of those new “potential managers”. It is arguably not the best use of his talents. On the same day that the Patient Capital Trust lost its patience with him, the UK government announced a £200m cash injection alongside £400m of private investment into precisely the type of unquoted science companies that Mr Woodford seeks to back. He may yet continue to do so, but not at WPCT. Judging by the board’s words, and Mr Woodford’s deeds — he sold a £1m stake but didn’t tell directors for three weeks — the curtain is coming down.»
----- ----- ----- ----- ----- -----
Anta, helt hypotetisk, at WPCT styret, enten selv, eller WPCTs nye forvalter, bestemmer seg for å selge WPCTs 50 millioner IDEX aksjer i markedet. Med vanlig IDEX volum, vil et slikt salg ta godt over ett år, og mest sannsynlig senke kursen, med mindre det skjer noe historisk reellt positivt i IDEX som fører til at CBE kan skimtes i det fjerne.
Hvis WPCT bestemmer seg for å selge WPCTs IDEX aksjer, hva gjør da Woodford med WEIFs IDEX aksjer?
Ingen ting, sitter rolig og satser på at IDEX ikke går konk og lykkes med smartkort, slik at kursen går opp - eller tar lærdom av feilene fra THIN, og selger WEIFs IDEX aksjer?
EDIT:
I andre FT artikler står det at WPCT styret i lengre tid har søkt etter en ny forvalter av WPCT. Hvis ingen annen forvalter vil ta over det skakkjørte fondet, hva gjør WPCT styret da? Forvalter det selv, eller avvikler/likviderer fondet?
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Et utdrag fra:
28.09.2019: https://www.ft.com/content/0da98d40-e12c-11e9-9743-db5a370481bc
Woodford on the brink of exit as trust results loom
Growing chorus to sack Patient Capital manager after latest writedowns
«Neil Woodford’s role as manager of the investment trust that bears his name looks ever more perilous following a spate of damaging writedowns and simmering tensions between Britain’s best-known stockpicker and the fund’s independent board.
Woodford Patient Capital Trust, which was the UK’s most successful listed fund launch when it opened five years ago, reports half-year results on Monday.
Its share price has halved this year, while its net asset value has dropped more than 13 per cent in the past few weeks after it was forced to mark down the value of several of its biggest holdings.
“I have been shocked by what the trust has recently announced,” said Ian Hunter, a professional investor and long-term shareholder in the fund. “Neil Woodford is not a fit and proper person to run it.”
The trust is also heavily in debt to US bank Northern Trust, and Mr Woodford was forced to accept new terms this month that allowed the Chicago lender to have a final say on any new investments he makes.
Overhanging the trust’s day-to-day problems is a more existential crisis: the board has lost confidence in Mr Woodford’s ability to run the portfolio and is actively courting new managers to replace him.
“The relationship between Woodford and the board is clearly ruptured — a change in manager is certainly likely,” said Alan Brierley, an analyst at Investec Securities who covers the trust.
At the centre of the dispute between Mr Woodford and the board is his decision to dump £1m of his personal shares in the trust in July, then not informing the board of the sale for another three weeks.
The board responded by announcing to the market that it had held talks with rival investment managers about displacing Mr Woodford, a disclosure it was not required to make. The FT reported in June that the board had already held discussions with its broker Winterflood Securities about terminating Mr Woodford’s contract.
“The share sales were outrageous on so many levels,” said a fund industry veteran who has close connections to the trust. “The fact that he thought it was OK to sell his stake without telling the board is absolutely shocking.”
Investors will be looking for more information from the WPCT board on Monday over its agreement with Northern Trust regarding a £150m overdraft facility. The board said in June that after consulting with concerned shareholders, it had agreed with Mr Woodford that he would gradually reduce the trust’s borrowing.
But the overdraft agreement with Northern Trust expires on January 16, giving the manager less than four months to pay back the debt or renegotiate the facility. Whether or not Mr Woodford will still be in place by that deadline is far from clear.
“Neil Woodford has destroyed a lot of value in the fund and the board has allowed him to do so,” said Mr Hunter. “Therefore he and the board must go.”»
28.09.2019: https://www.ft.com/content/0da98d40-e12c-11e9-9743-db5a370481bc
Woodford on the brink of exit as trust results loom
Growing chorus to sack Patient Capital manager after latest writedowns
«Neil Woodford’s role as manager of the investment trust that bears his name looks ever more perilous following a spate of damaging writedowns and simmering tensions between Britain’s best-known stockpicker and the fund’s independent board.
Woodford Patient Capital Trust, which was the UK’s most successful listed fund launch when it opened five years ago, reports half-year results on Monday.
Its share price has halved this year, while its net asset value has dropped more than 13 per cent in the past few weeks after it was forced to mark down the value of several of its biggest holdings.
“I have been shocked by what the trust has recently announced,” said Ian Hunter, a professional investor and long-term shareholder in the fund. “Neil Woodford is not a fit and proper person to run it.”
The trust is also heavily in debt to US bank Northern Trust, and Mr Woodford was forced to accept new terms this month that allowed the Chicago lender to have a final say on any new investments he makes.
Overhanging the trust’s day-to-day problems is a more existential crisis: the board has lost confidence in Mr Woodford’s ability to run the portfolio and is actively courting new managers to replace him.
“The relationship between Woodford and the board is clearly ruptured — a change in manager is certainly likely,” said Alan Brierley, an analyst at Investec Securities who covers the trust.
At the centre of the dispute between Mr Woodford and the board is his decision to dump £1m of his personal shares in the trust in July, then not informing the board of the sale for another three weeks.
The board responded by announcing to the market that it had held talks with rival investment managers about displacing Mr Woodford, a disclosure it was not required to make. The FT reported in June that the board had already held discussions with its broker Winterflood Securities about terminating Mr Woodford’s contract.
“The share sales were outrageous on so many levels,” said a fund industry veteran who has close connections to the trust. “The fact that he thought it was OK to sell his stake without telling the board is absolutely shocking.”
Investors will be looking for more information from the WPCT board on Monday over its agreement with Northern Trust regarding a £150m overdraft facility. The board said in June that after consulting with concerned shareholders, it had agreed with Mr Woodford that he would gradually reduce the trust’s borrowing.
But the overdraft agreement with Northern Trust expires on January 16, giving the manager less than four months to pay back the debt or renegotiate the facility. Whether or not Mr Woodford will still be in place by that deadline is far from clear.
“Neil Woodford has destroyed a lot of value in the fund and the board has allowed him to do so,” said Mr Hunter. “Therefore he and the board must go.”»
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
nima
27.09.2019 kl 15:48
4526
Å putte penger i IDEX er det samme som å betale søppelavgift, bort blir alt, bare søppeldunken står igjen
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
H-Capital
27.09.2019 kl 15:40
4537
Ny low for aksjen idag siden 2014. Nå åpnes portene mot 1,00 og 50 øre i mitt hode..
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
H-Capital
27.09.2019 kl 08:02
4614
Slettet brukerskrev Hvilket fond er mest kritisk for Idex
WEIF eier 19,99% av IDEX. - dette fondet er sperret for uttak til desember(guiding p.t) og vil sannsynligvis få ny forvalter..
WPCT eier 8,37% av IDEX - dette er open ended fund, og har falt nesten 50% på børs siden mai. Markedet priser fondet til ca 50% rabatt av hva Woodford mener er NAV.
Det er en fair sjanse for at WF skal ut med begge postene her. Så spørs det bare når og hvor.
WPCT eier 8,37% av IDEX - dette er open ended fund, og har falt nesten 50% på børs siden mai. Markedet priser fondet til ca 50% rabatt av hva Woodford mener er NAV.
Det er en fair sjanse for at WF skal ut med begge postene her. Så spørs det bare når og hvor.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
H-Capital
26.09.2019 kl 21:37
3138
Det er WEIF. Se side 33
https://static.woodfordfunds.net/prd/2019/05/LF-WEIF_Annual-Report_181231.pdf
https://static.woodfordfunds.net/prd/2019/05/LF-WEIF_Annual-Report_181231.pdf
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Mer fra artikkelen i mitt siste innlegg over, som er blitt oppdatert og 4x lengre, siden jeg lastet den i en fane tidligere i dag.
----- ----- ----- ----- ----- -----
Et utdrag fra:
26.09.2019: https://www.ft.com/content/5ef869d0-e02f-11e9-9743-db5a370481bc
Woodford investment trust hit by triple writedowns
Latest development deals further body blow to UK stockpicker Neil Woodford
«WPCT’s share price was on Thursday trading at a 32 per cent discount to its net asset value.
Christopher Brown, an analyst at JPMorgan Cazenove, said Thursday’s writedowns would cut the fund’s net asset value by 4.6 per cent, bringing the total reduction to 13.3 per cent since the first markdown in late August.
“It looks increasingly likely that the company that bears Woodford’s name will move to another manager, and we would then hope for a controlled liquidation, which is likely to be the most effective way to close the [roughly] 30 per cent discount, although over the long term it is anybody’s guess how the remaining portfolio will perform,” wrote Mr Brown.»
----- ----- ----- ----- ----- -----
En JPMorgan analytiker spekulerer i at Woodford blir fratatt forvaltningen av WPCT, og at fondet blir likvidert.
Gi_Fan, du som har oversikten, er det WPCT eller WEIF som har den største IDEX posten på 19,99%?
----- ----- ----- ----- ----- -----
Et utdrag fra:
26.09.2019: https://www.ft.com/content/5ef869d0-e02f-11e9-9743-db5a370481bc
Woodford investment trust hit by triple writedowns
Latest development deals further body blow to UK stockpicker Neil Woodford
«WPCT’s share price was on Thursday trading at a 32 per cent discount to its net asset value.
Christopher Brown, an analyst at JPMorgan Cazenove, said Thursday’s writedowns would cut the fund’s net asset value by 4.6 per cent, bringing the total reduction to 13.3 per cent since the first markdown in late August.
“It looks increasingly likely that the company that bears Woodford’s name will move to another manager, and we would then hope for a controlled liquidation, which is likely to be the most effective way to close the [roughly] 30 per cent discount, although over the long term it is anybody’s guess how the remaining portfolio will perform,” wrote Mr Brown.»
----- ----- ----- ----- ----- -----
En JPMorgan analytiker spekulerer i at Woodford blir fratatt forvaltningen av WPCT, og at fondet blir likvidert.
Gi_Fan, du som har oversikten, er det WPCT eller WEIF som har den største IDEX posten på 19,99%?
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Et utdrag fra:
26.09.2019: https://www.ft.com/content/5ef869d0-e02f-11e9-9743-db5a370481bc
Woodford investment trust hit by further writedowns
Trust has been forced to write down a succession of holdings
«Neil Woodford’s investment trust has been forced to write down the value of three more of its holdings, in a further body blow to Britain’s best-known stockpicker.
The share price of Woodford Patient Capital Trust fell nearly 7 per cent as the market opened on Thursday morning, marking a 50 per cent fall so far this year. The trust has been forced to write down a succession of holdings in the past month alone.
“These valuation adjustments reflect the challenging fundraising environment for these businesses which may impact their ability to or the level at which they may be able to raise capital in the near-term,” the board said in a statement.
WPCT is due to report its half-year results on Monday.»
26.09.2019: https://www.ft.com/content/5ef869d0-e02f-11e9-9743-db5a370481bc
Woodford investment trust hit by further writedowns
Trust has been forced to write down a succession of holdings
«Neil Woodford’s investment trust has been forced to write down the value of three more of its holdings, in a further body blow to Britain’s best-known stockpicker.
The share price of Woodford Patient Capital Trust fell nearly 7 per cent as the market opened on Thursday morning, marking a 50 per cent fall so far this year. The trust has been forced to write down a succession of holdings in the past month alone.
“These valuation adjustments reflect the challenging fundraising environment for these businesses which may impact their ability to or the level at which they may be able to raise capital in the near-term,” the board said in a statement.
WPCT is due to report its half-year results on Monday.»
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Et utdrag fra:
09.08.2019: https://www.ft.com/content/ff03c868-b850-11e9-8a88-aa6628ac896c
Woodford equity fund tops list of UK underachievers
«Neil Woodford’s stricken Equity Income fund has been named as the worst-performing UK fund in a list of serial underachievers, capping a dismal period for the former star stockpicker that culminated in the gating of his flagship investment vehicle.
The inclusion of the £3.7bn fund in online investment company Bestinvest’s twice yearly “Spot the Dog” report will sit badly with investors whose money remains locked inside it. Woodford Investment Management froze trading in the fund on June 3 after a surge in redemption requests in response to poor performance led to a liquidity crunch.
According to Bestinvest, investors who remain in the fund have chalked up a 20 per cent loss in real terms over the three years to the end of June, with an initial investment of £100 being reduced to just £80 after the reinvestment of any dividends.
The fund, which is skewed towards out-of-favour UK stocks and has also suffered due to bad bets on companies such as Provident Financial and Prothena, delivered the worst performance of the 59 “dog” funds on the Bestinvest list, having lagged behind the wider market by 38 per cent over the period.»
----- ----- ----- ----- ----- -----
De 2 største IDEX aksjonærene, Woodford og Invesco, topper listen over dårligste UK fonds-forvaltere siste 3 år (screenshot fra artikkelen over):
http://vxz.eu/2019-08-09__FT__Ten-biggest_'dog'-funds
09.08.2019: https://www.ft.com/content/ff03c868-b850-11e9-8a88-aa6628ac896c
Woodford equity fund tops list of UK underachievers
«Neil Woodford’s stricken Equity Income fund has been named as the worst-performing UK fund in a list of serial underachievers, capping a dismal period for the former star stockpicker that culminated in the gating of his flagship investment vehicle.
The inclusion of the £3.7bn fund in online investment company Bestinvest’s twice yearly “Spot the Dog” report will sit badly with investors whose money remains locked inside it. Woodford Investment Management froze trading in the fund on June 3 after a surge in redemption requests in response to poor performance led to a liquidity crunch.
According to Bestinvest, investors who remain in the fund have chalked up a 20 per cent loss in real terms over the three years to the end of June, with an initial investment of £100 being reduced to just £80 after the reinvestment of any dividends.
The fund, which is skewed towards out-of-favour UK stocks and has also suffered due to bad bets on companies such as Provident Financial and Prothena, delivered the worst performance of the 59 “dog” funds on the Bestinvest list, having lagged behind the wider market by 38 per cent over the period.»
----- ----- ----- ----- ----- -----
De 2 største IDEX aksjonærene, Woodford og Invesco, topper listen over dårligste UK fonds-forvaltere siste 3 år (screenshot fra artikkelen over):
http://vxz.eu/2019-08-09__FT__Ten-biggest_'dog'-funds
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
nerfherder
16.09.2019 kl 18:16
3443
Woodford har satset store penger på en type selskap, og nå viser det seg at de feiler en etter en.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Et utdrag fra:
16.09.2019: https://ftalphaville.ft.com/2019/09/16/1568627662000/BenevolentAI-gets-cut-in-half
BenevolentAI gets cut in half
«BenevolentAI, the tech company backed by Neil Woodford, is set to see its valuation halved in its latest funding round, reported the Sunday Times yesterday.
Valued at $2bn in April 2018 after it raised $115m, it is reported BenevolentAI is expecting its latest valuation to come in at just $1bn, following an investment from Singaporean sovereign wealth fund Temasek.
FT Alphaville analysis suggested that just under a fifth of BenevolentAI’s shares were owned by Woodford’s Equity Income Fund and the Patient Capital Trust, as of 16 September 2018.
Investors who will be taking a bath include the two Woodford investment vehicles, Goldman Sachs, Dragons’ Den’s Richard Farleigh, and various entities linked to Minnesota’s Evenstad family, who privately own Upsher-Smith Laboratories.»
----- ----- ----- ----- ----- -----
Woodford er god til å plukke taperaksjer.
16.09.2019: https://ftalphaville.ft.com/2019/09/16/1568627662000/BenevolentAI-gets-cut-in-half
BenevolentAI gets cut in half
«BenevolentAI, the tech company backed by Neil Woodford, is set to see its valuation halved in its latest funding round, reported the Sunday Times yesterday.
Valued at $2bn in April 2018 after it raised $115m, it is reported BenevolentAI is expecting its latest valuation to come in at just $1bn, following an investment from Singaporean sovereign wealth fund Temasek.
FT Alphaville analysis suggested that just under a fifth of BenevolentAI’s shares were owned by Woodford’s Equity Income Fund and the Patient Capital Trust, as of 16 September 2018.
Investors who will be taking a bath include the two Woodford investment vehicles, Goldman Sachs, Dragons’ Den’s Richard Farleigh, and various entities linked to Minnesota’s Evenstad family, who privately own Upsher-Smith Laboratories.»
----- ----- ----- ----- ----- -----
Woodford er god til å plukke taperaksjer.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Mulla3 skrev Hvor stor er belåningen i Idex.
Hva mener du ?
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Mulla3
09.09.2019 kl 19:55
3789
Hvor stor er belåningen i Idex.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
BNP Paribas er vel Abu Dhabi. De kom seg jo etterhvert helt ut av thin som den 2 institusjonelle investoren (etter First som gjorde det raskt og effektivt og reddet i alle fall litt av fondseiernes penger). Kanskje de ønsker å komme seg ut av idex før det kommer så langt som til øre priser. Ser jo langt igjen ut dit nå, men en høst uten meldinger med substans og et emisjonsforsøk som mislykkes så går det ganske fort
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
nerfherder
09.09.2019 kl 18:23
3842
BNP Paribas kan tydeligvis ikke komme seg fort nok ut. Vil vel prøve å klare det før emi.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Møyfrid
09.09.2019 kl 11:14
3925
Verdenslederen mener det alltid tar av, både FØR, NÅ og fremover.
Mulig de egentlig snakker om utgiftene.
Mulig de egentlig snakker om utgiftene.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Nå er det en pågående sertifisering i Kina. Innen utgangen av september skal den være ferdig. Hva om den kommer med godt utfall ?
Og. Woodford har som strategi å sitte på undervurderte aksjer. Selv om han skal selge seg ut av illikvide. Hva om det er strategi å sitte i Idex. At han ikke er innelåst uten exitmuligheter, men avventer markedet. At han avviser exitmuligheter, for å sitte på oppidepotensialet. Posten han sitter på er betydelig, og representerer en strategisk mulighet.
Vi er enig i at kassen er tom før utgangen av 1. Q -2020. Idex har hatt anledning til å trimme kostnadssiden. Trimming av kostnader, er reduserte vekstmuligheter og markedsandeler når dette tar av. Og, idex mener det tar av NÅ og fremover.
Og. Woodford har som strategi å sitte på undervurderte aksjer. Selv om han skal selge seg ut av illikvide. Hva om det er strategi å sitte i Idex. At han ikke er innelåst uten exitmuligheter, men avventer markedet. At han avviser exitmuligheter, for å sitte på oppidepotensialet. Posten han sitter på er betydelig, og representerer en strategisk mulighet.
Vi er enig i at kassen er tom før utgangen av 1. Q -2020. Idex har hatt anledning til å trimme kostnadssiden. Trimming av kostnader, er reduserte vekstmuligheter og markedsandeler når dette tar av. Og, idex mener det tar av NÅ og fremover.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
H-Capital
09.09.2019 kl 10:12
3979
En litt artig kommentar til q2 er at de i presentasjonen sin (slide 15) skriver at de vil ha "OPEX levels Expected to be stable for remainder of 2019. Stable organization size expected". Den var ved q2 negativ 63mNok.. Dvs at de implisitt forventer å gå tom for cash jan.2020. MEN likevel guider de på conf call at de er positive til sin tidligere plan om break even ila 2019. Hehe. Er litt stakkarslig.
De har også en figur i presentasjonen som viser 5 mrd units med fingersensor i 2023, men i bunnen av presentasjonen er dette endret til 2021.
De har også en figur i presentasjonen som viser 5 mrd units med fingersensor i 2023, men i bunnen av presentasjonen er dette endret til 2021.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Det ville henge mer på greip om det var en utviklingskontrakt. Det har jeg opplevd flere ganger at har blitt sponset av sluttkunde for produktene, men de bruker å holde seg langt unna elektronikk-produksjon og komponentkjøp.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
voiceofreason
08.09.2019 kl 21:27
4106
you have said on here that they were told that buying stock is an attempt at price manipulation. It is a crazy statement , especially as it went on for many days. So I'm asking you for evidence to support that statement. Should be very easy to do. the local regulator will have sent out a notice.
Where is the link please? you don't want to look as though you are making things up do you?
Where is the link please? you don't want to look as though you are making things up do you?
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Sente
08.09.2019 kl 21:17
4115
I agree somewhat.
With reference to the press release, the deal is "upgrade their existing biometric security solutions.". So Idex is selling more then just the sensors/modules as I understand it.
However, I would expect "Bloomberg" to make the order from Feitian, or some other company, that actually makes the cards and NFC readers.
Also, I wonder if this is related:
https://twitter.com/IDEXBiometrics/status/1146466513316171777
"Congratulations to the IDEX Software Engineering team for successfully completing the recent release for our financial services provider client!"
With reference to the press release, the deal is "upgrade their existing biometric security solutions.". So Idex is selling more then just the sensors/modules as I understand it.
However, I would expect "Bloomberg" to make the order from Feitian, or some other company, that actually makes the cards and NFC readers.
Also, I wonder if this is related:
https://twitter.com/IDEXBiometrics/status/1146466513316171777
"Congratulations to the IDEX Software Engineering team for successfully completing the recent release for our financial services provider client!"
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
nerfherder
08.09.2019 kl 19:04
4158
Men blir spennende å se i morgen om BNP paribas fortsetter å selge.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
nerfherder
08.09.2019 kl 19:03
4159
Er ikle drøyt, når man kjøper 50k aksjer om dagen fremfor å ta det i ett jafs
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Det er ganske drøyt å påstå at en ny CFO og nytt styremedlem skal stå for kursmanipulasjon med en gang de er ansatt? Så vil det snart vise seg om Stanley er verdt pengene. Nettverk og bakgrunn har han.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Jeg er helt enig at innsidekjøp aldri negativt, i alle fall om det ikke lukter kurs-pleie som endel av de tidligere i samme selskap. Og det var jo en tåpelig måte å handle på om motivet var å tjene penger, eller var det slik at troen hans øket dag for dag? Nok til å bestemme seg for å kjøpe 50k til, ikke mer, ikke mindre.
Om han hadde visst at det ikke var håp, at det ikke blir noe raskt voksende BSC marked og at Idex er dårlig utrustet til å konkurrere om det skulle komme, så ville det være å kaste penger ut av vinduet. Men han tror kanskje på Stan han også, Stan er en god historie forteller og har med de fleste riktige ordene.
Om han hadde visst at det ikke var håp, at det ikke blir noe raskt voksende BSC marked og at Idex er dårlig utrustet til å konkurrere om det skulle komme, så ville det være å kaste penger ut av vinduet. Men han tror kanskje på Stan han også, Stan er en god historie forteller og har med de fleste riktige ordene.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Might be correct. But, working in technology, I find it very strange that Bloomberg or Thomson Reuters place an order on Idex. They would basically have zero competence in buying electronics parts. The orders would normally come from the company actually building the end product, or even a sub system assembler (BSC module). I am not saying that it's it's something fishy with the order, but it is certainly extraordinary.
Additionally, for the technical merits, it the rumors are correct, this would be a battery powered card (at least the rumors I have seen is that it's not a payment card, but it's some kind of token generator for access to services and those would obviously need a battery).
Additionally, for the technical merits, it the rumors are correct, this would be a battery powered card (at least the rumors I have seen is that it's not a payment card, but it's some kind of token generator for access to services and those would obviously need a battery).
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Forskjell på å risikere huset og regelrett kaste pengene ut av vinduet? Synes det er bra jeg at nyansatte ledere kjøper aksjer og har stake in the game.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Om det er betydlig eller ikke kommer vel an på hvem som handler.
Edit, litt lite oversikt på telefon. Men at Stephen Skaggs har inside handler på MUSD i Atmel og Coherent og har neppe satset huset sitt på 450k Idex, dog ikke så store beløp som jeg feilaktig skrev (om noen leste det)
Edit, litt lite oversikt på telefon. Men at Stephen Skaggs har inside handler på MUSD i Atmel og Coherent og har neppe satset huset sitt på 450k Idex, dog ikke så store beløp som jeg feilaktig skrev (om noen leste det)
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
voiceofreason
08.09.2019 kl 16:39
4208
ha! evidence please. It would be all over OSE's news service. Please provide the link!! :)
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
nerfherder
08.09.2019 kl 16:24
4216
Innsidekjøpet tok kjapt slutt da de fikk beskjed om at det ble sett på som forsøk på kursmanipulasjon.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Innsidekjøp av rykende fersk CFO og nytt styremedlem. Ganske betydelig også, er jo ikke penger ut av vinduet. De vil være med når det smeller tenker jeg. De andre har jo tildelinger på millioner av aksjer. Problemet er at mye av det er out of money på kurs 1,65 er det vel?.. Skyggen som utgjøres av et mulig stort nedsalg av Woodford skaper naturligvis usikkerhet. Men hva vet vi egentlig? Det kan være noen tar over aksjeposten? At så mange aksjer skal omsettes over børs tror jeg lite på. De venter nok som oss på gjennombruddsmelding og da med økt interesse vil de finne en større aktør som vil være med videre. Det er også åpning for at de blir sittende en stund fremover?
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
voiceofreason
08.09.2019 kl 15:57
4176
Regarding this order from a global payment provider: I think the revenue number 8s going to be comparatively small and not too significant.
I think the significance of it is is rather that somebody the size of Bloomberg or Thomson Reuters have done their due diligence on the available technology and chosen Idex's solution.
I think the significance of it is is rather that somebody the size of Bloomberg or Thomson Reuters have done their due diligence on the available technology and chosen Idex's solution.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
voiceofreason
08.09.2019 kl 15:54
4177
well I work in finance and disagree with you. If you check back to the capital raise there was clear competition between investors to invest more (the raise was at 25% premium to the shares stock price if you remember). Woodford accounted for the majority of that but it shows he had competition and had to pay up for his allocation. SHOULD certification go well (and it is by no means a certainty) then the demand will be high for any further capital increase. I personally think the capital increase will have to happen but if certification is successful then I expect the stock price to be significantly higher than the current level so dilution won't be much of an issue (I don't agree that three years worth of funding will be sought as you suggest!). What surprises me is that insiders that we know of (bear in mind not ALL employees are classified as insiders and thus don't have to report their shareholding activity) are purchasing currently which suggests a confidence level that there may not be a capital raise and of course they have greater knowledge than anyone on these forums. Interesting times.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Gi_F: jeg liker måten du tenker på og synser. Jeg liker også å trekke linjene og sannsynliggjøre utfall. Spørsmålet vi bør stille oss er: hva inneholder neste børsmelding? Vi forventer en oppdatering i september som jeg har vært inne på mange ganger. Vi får se om den flotte oppgangen fra fredag fortsetter i morgen?.. Forventningsrally? Jeg tenker ja.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare
Det burde/bør komme en leveranse nå i September på meldingen fra 4/30. Med 4 måneders ledetid skulle Idex være klar til å levere nå.
Det er ikke sikkert at Idex vil melde det. Jeg synes de burde melde salg, for forventingene i markedet er vel 0 salg. Idex kan likevel ha sitt på det tørre uten å melde leveringen for de har jo alltid snakket om store leveranser i nær fremtid i presentasjonene. Men har idex noen gang latt en mulighet for en melding med substans gå fra seg? De er jo mestere i meldinger uten konkret informasjon, men det er ikke noen historikk med konkrete meldinger (for det har vel ikke vært noen slike hendelser). Nå så nær en emisjon tror jeg definitivt det vil bli meldt. Spørsmålet er om de kommer med en tåkemelding i forhold til hva det betyr på topplinje eller ikke.
Har også prøvd å spekulere i hvor stor en slik leveranse kan være. Uten å være regnskapskyndig, så tror jeg at en skulle se verdien av ordre lagt på underleverandører på "prepaid expenses" og "accounts payable". Summen av disse økte med ca 1.3MNOK i Q2, noe som kunne tilsi ca 2.6MNOK om idex kan selge med 50% GM.
Men det er så mye annet som går i disse postene så det er ingen presisjon i et slikt estimat. Dog tror jeg det er klart at det ikke er "million dollar", ikke engang "single", i denne omgang, for da ville økning i forskuddsbetaling og leverandørgjeld vært mer synlig.
Det er ikke sikkert at Idex vil melde det. Jeg synes de burde melde salg, for forventingene i markedet er vel 0 salg. Idex kan likevel ha sitt på det tørre uten å melde leveringen for de har jo alltid snakket om store leveranser i nær fremtid i presentasjonene. Men har idex noen gang latt en mulighet for en melding med substans gå fra seg? De er jo mestere i meldinger uten konkret informasjon, men det er ikke noen historikk med konkrete meldinger (for det har vel ikke vært noen slike hendelser). Nå så nær en emisjon tror jeg definitivt det vil bli meldt. Spørsmålet er om de kommer med en tåkemelding i forhold til hva det betyr på topplinje eller ikke.
Har også prøvd å spekulere i hvor stor en slik leveranse kan være. Uten å være regnskapskyndig, så tror jeg at en skulle se verdien av ordre lagt på underleverandører på "prepaid expenses" og "accounts payable". Summen av disse økte med ca 1.3MNOK i Q2, noe som kunne tilsi ca 2.6MNOK om idex kan selge med 50% GM.
Men det er så mye annet som går i disse postene så det er ingen presisjon i et slikt estimat. Dog tror jeg det er klart at det ikke er "million dollar", ikke engang "single", i denne omgang, for da ville økning i forskuddsbetaling og leverandørgjeld vært mer synlig.
Redigert 20.01.2021 kl 19:54
Du må logge inn for å svare